Central Nervous System Neoplasms
📧 Sign up to get email alerts when something new happens for Central Nervous System Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Cerebrospinal Fluid Biomarkers for Brain Tumors
A Mayo Clinic-sponsored clinical trial is investigating cerebrospinal fluid biomarkers for brain tumors and is currently recruiting particip…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors [Phase 1]
Phase 1 trial updating the investigation of HSV-1 G207 for children with recurrent or refractory cerebellar brain tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases [Phase 2]
A Phase 2 clinical trial is evaluating single-fraction versus multifraction salvage spine stereotactic radiosurgery for previously irradiate…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System [Phase 2]
Phase 2 clinical trial evaluating gadolinium-based contrast agents with ferumoxytol-enhanced MRI to diagnose abnormalities in the central ne…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial evaluating CBL0137 for relapsed or refractory solid tumors, including central nervous system t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery [NA]
This clinical trial is evaluating a clinical prediction model to predict surgical site infection after central nervous system tumor surgery.…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors [Phase 1]
Clinical trial update indicating that Loc3CAR (B7-H3-CAR T cells) delivery is in early-phase pediatric CNS tumor trials and currently recrui…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors [Phase 1]
Phase 1 clinical trial evaluating a neoepitope-based personalized DNA vaccine in pediatric patients with recurrent central nervous system tu…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study of Metabolic Agents Following Brain Radiation
Completed clinical trial evaluating metabolic agents following brain radiation for central nervous system neoplasms. The snippet provides no…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Circulating microRNAs as Disease Markers in Pediatric Cancers
A completed study evaluating circulating microRNAs as biomarkers for pediatric cancers, including leukemia, lymphoma, and central nervous sy…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Retrospective Study of MRI in Pediatric Patients
This document reports a completed retrospective study evaluating MRI use in pediatric patients with central nervous system diseases, includi…
-
CLINICAL_TRIALS research · 2010-10-27Clinical Trial Update: CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan [Phase 2]
Phase 2 clinical trial update evaluating CT-322 with irinotecan for recurrent glioblastoma multiforme; sponsored by Adnexus (a Bristol-Myers…